Richard Lehman’s journal review—14 December 2015

NEJM 10 Dec 2015 Vol 373 Pacific treatments for scabies 2305 Wow. Here is the ultimate cluster randomised trial: an island randomised trial. First find your islands in the vastness of the Pacific Ocean. Make sure they are big enough for your power calculation, and that they have a similar prevalence of your target condition: […]

Read More…

Richard Lehman’s journal review—7 December

NEJM 3 Dec 2015 Vol 373 CPR with or without breaks 2203 Cardiopulmonary resuscitation for cardiac arrest outside hospital carries a mortality risk of more than 90%. It is usually assumed that the death rate would otherwise be 100%, but trials of CPR don’t ever include a non-intervention arm, so we don’t really know. In […]

Read More…

Richard Lehman’s journal review—30 November

NEJM 26 Nov 2015 Vol 373 “Artificial cell” for diabetes 2129 “Home use of an artificial beta cell in type 1 diabetes” conjures up a vision of some huge cellular blob taken home in a glass tank and connected up with the circulation, probably by Peter Cushing in a white coat and half-moon spectacles. In […]

Read More…

Richard Lehman’s journal review—23 November 2015

NEJM 19 Nov 2015 Vol 373 Spooky RSV trial 2048 There’s a hint of Porton Down about this phase 1 study of an oral treatment for respiratory syncytial virus (RSV). The 62 volunteers trooped in and the steel doors shut behind them. Two days later, masked personnel in white coats proceeded to inoculate them intranasally […]

Read More…

Richard Lehman’s journal review—9 November 2015

NEJM  5 Nov 2015  Vol 373 Now for the good news 1824   In the middle of the joy and uncertainty of pregnancy, you are told you have cancer. It happens to a few women every week across Europe. Thanks to a collaboration between national referral centres in Belgium, the Netherlands, Italy, and the Czech Republic […]

Read More…

Richard Lehman’s journal review—2 November 2015

NEJM 29 Oct 2015 Vol 373 Noddy meets oncology 1679 PARP stands for poly(adenosine diphosphate [ADP]–ribose) polymerase. For every child who grew up in England since the 1950s, it is also the noise that Noddy’s car makes. Now there is a PARP inhibitor called olaparib which costs about £900 a week for treating metastatic cancers […]

Read More…

Richard Lehman’s journal review—26 October 2015

NEJM 22 October 2015 Vol 373 Neatest knee trial 1597 “Whatever next. A patient centred, surgical RCT on a common operation with a thoughtful, patient centred editorial in the NEJM,” wrote a friend on the day this paper appeared. Like minded messages and tweets poured in from both sides of the Atlantic. This randomised trial […]

Read More…

Richard Lehman on prescribing spironolactone

The liveliest e-mail streams I have ever encountered are the ones which are currently coming out of the Overdiagnosis Group, set up by Margaret McCartney last year. The group is now a standing body within the Royal College of General Practitioners and most of its members are working GPs. But there are participants from all […]

Read More…